Article
Molecular and biological changes in the cold-adapted "master strain" A/AA/6/60 (H2N2) influenza virus.
Proceedings of the National Academy of Sciences of the United States of America - 1 Jul 1993
Herlocher M L, Maassab H F, Webster R G
Abstract excerpt
The live cold-adapted (ca) A/AA/6/60 influenza vaccine is being commercially developed for worldwide use in children and is being used as a model for other live vaccines. Although it has been proven safe and immunogenic, the molecular basis of cold adaptation has never been determined. To identify sequence changes responsible for cold adaptation, we have compared the sequence of the master ca vaccine strain to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
